Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Calcitriol + Temozolomide in Metastatic Melanoma
NCT00301067Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Jan 2005
- Primary completion
- Apr 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of calcitriol in melanoma, sponsored by Northwestern University. Started Jan 2005; status: completed.
02
Drugs
calcitriol
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00301067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00301067.